Physician profile
Eric L Dodson
NPI 1851384465
$1,213.96
in general payments reported to CMS, 2019-2025
16 companies · $112 in 2025
The $112 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.33 · 2020: $48.97 · 2021: $177 · 2022: $199 · 2023: $214 · 2024: $369 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $389.47 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $174.03 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $107.85 | 2021-2025 | Vaxneuvance, Vaxelis, Rotateq |
| Sanofi Pasteur INC. | $81.82 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $70.76 | 2021-2023 | Qelbree |
| Glaxosmithkline, LLC. | $69.12 | 2024-2025 | Bexsero, Pediarix, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $56.54 | 2020-2022 | |
| Pfizer INC. | $49.46 | 2023-2024 | |
| Adlon Therapeutics L.P. | $48.84 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $42.22 | 2023-2024 | Flumist Quadrivalent |
| Seqirus USA INC | $39.17 | 2022-2024 | Flucelvax, Flucelvax Quadrivalent |
| Collegium Pharmaceutical, INC. | $22.21 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $18.74 | 2024 | Doc Band |
| Sanofi-Aventis U.S. LLC | $14.62 | 2025 | |
| Kaleo, INC. | $14.62 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Dodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.